Erler A
Zentrum für Human- und Gesundheitswissenschaften der Berliner Hochschulmedizin Institut für Soziale Medizin, Germany.
Gesundheitswesen. 2002 Nov;64(11):572-7. doi: 10.1055/s-2002-35538.
On 1st January 2002 a law was enacted by the German Federal Government reorganising the reinsurance pool known as the "risk compensation scheme" (RSA) of the German health insurance system. This enactment contemplates a gradual restructuring of the RSA to shift from a system that considered only certain demographic criteria to one that reflects actual morbidity rates, with the shift to be phased in before full implementation by 2007. The enactment also introduced disease management programmes (DMP) for patients with certain chronic illnesses. Insurance companies will now receive additional payments from the RSA for patients with a chronic condition who are enrolled in a DMP. The intent is to improve the poor medical care for chronically ill patients in Germany - as had been stated by the advisory council of the Concerted Action in Health Care - and to reduce the natural tendency of insurance companies to prefer young healthy members over chronically ill patients. Possible consequences of the legal changes are discussed from the point of view of the various insurance companies as well as the Federal Association of Statutory Health Insurance Physicians.
2002年1月1日,德国联邦政府颁布了一项法律,对德国医疗保险体系中被称为“风险补偿计划”(RSA)的再保险池进行重组。该法令设想对RSA进行逐步重组,从仅考虑某些人口统计学标准的体系转变为反映实际发病率的体系,并在2007年全面实施之前分阶段进行转变。该法令还为某些慢性病患者引入了疾病管理计划(DMP)。保险公司现在将从RSA获得额外付款,用于参加DMP的慢性病患者。其目的是改善德国慢性病患者糟糕的医疗护理状况——正如医疗保健协调行动咨询委员会所指出的那样——并减少保险公司倾向于选择年轻健康成员而非慢性病患者的自然倾向。从各保险公司以及法定医疗保险医生联邦协会的角度讨论了法律变更可能产生的后果。